Follow The Filings

DAR Darling Ingredients

Darling Ingredients earnings company data as of 9:59 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 1.86 — —
Rev — — —

Insider trades

Open-market buys and sales by DAR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All DAR insider trades
  • $61K bought by 1 insider
  • $5.3M sold by 6 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Randall C Stuewe CEO
    Sale
    $341K 5,000 shares at $68.20 0.4% of stake
    Traded Sep 2 Filed Sep 4
  2. Joseph Manzi Chief Accounting Officer
    Sale
    $67K 1,000 shares at $67.27 5% of stake
    Traded Aug 18 Filed Aug 18
  3. Sandra Dudley EVP Chief Strategy Officer
    Sale
    $439K 6,474 shares at $67.87 8% of stake
    Traded Aug 17 Filed Aug 18
  4. Patrick McNutt EVP Chief Admin Officer
    Sale
    $537K 8,000 shares at $67.09 18% of stake
    Traded Aug 14 Filed Aug 14
  5. Randall C Stuewe CEO
    Sale
    $640K 10,000 shares at $64.03 0.9% of stake
    Traded Aug 12–13 Filed Aug 14
  6. Nicholas James Kemphaus EVP Gen. Counsel & Secretary
    Sale
    $100K 1,591 shares at $63.05 4.3% of stake
    Traded Aug 10 Filed Aug 10
  7. Charles L Adair Director
    Buy
    $61K 1,000 shares at $60.97 +2% to stake
    Traded Jul 31 Filed Aug 3
  8. Joseph Manzi Chief Accounting Officer
    Sale
    $192K 3,000 shares at $63.89 13% of stake
    Traded May 1 Filed May 1
  9. Randall C Stuewe CEO
    Sale
    $1M 20,000 shares at $52.12 1.8% of stake
    Traded Mar 6 Filed Mar 10
  10. Jan Van Der Velden EVP Int Rendering&Specialties
    Sale
    $1.2M 23,000 shares at $51.23 24% of stake
    Traded Feb 17–18 Filed Feb 19
  11. Sandra Dudley EVP Chief Strategy Officer
    Sale
    $448K 8,651 shares at $51.78 11% of stake
    Traded Feb 13 Filed Feb 17
  12. Nicholas James Kemphaus EVP Gen. Counsel & Secretary
    Sale
    $304K 5,830 shares at $52.14 15% of stake
    Traded Feb 13 Filed Feb 17

Also filed in the last 12 months, not counted as buying or selling: 39 stock grants, 26 share withholdings for taxes, 6 option exercises, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 7.01,9.01
SCHEDULE 13G —
8-K 2.02,7.01,9.01
8-K 7.01,9.01
10-Q
8-K 5.07
8-K 2.02,7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.